A friend started researching weight-loss options last winter and got genuinely confused fast. Every platform claimed to be “the best,” prices were buried behind signup walls, and half the brands she bookmarked had quietly changed what they offered by the time she circled back. Orforglipron, Lilly’s oral GLP-1 candidate, was just entering the picture. The options multiplied. This list tries to cut through that mess.
These 11 picks are grouped by what different readers actually need, not by an arbitrary overall rank.
Best If You Want GLP-1s and Peptides Under One Roof
1. FormBlends
Most weight-loss telehealth brands sell one category of thing. Most peptide sellers are research-only outfits with no prescriber in the loop. FormBlends does something different: a licensed physician reviews your intake, then the pharmacy that fills your order is a 503A, FDA-inspected, cGMP facility, not a gray-market supplier. That distinction matters more now than it did two years ago.
The catalog is genuinely wide. GLP-1 options sit alongside retatrutide at $389 per vial, cagrilintide at $279, and a full peptide roster covering recovery compounds, nootropics, and longevity peptides. Semaglutide is $299 per vial and tirzepatide is $349. Those prices are visible before you hand over a credit card. No membership fee stacked underneath.
Delivery covers 47 states, with cold-chain handling included in the order. Compounded medications are not FDA-approved, and the peptide evidence base beyond GLP-1s is mostly preclinical. That is worth knowing going in.
The single practical advantage for someone tracking orforglipron’s arrival is this: if Lilly’s oral option changes your calculus, the same physician relationship and the same platform already covers what you might switch to or stack with.
Best for Oral Orforglipron Specifically
2. LillyDirect
Lilly has been positioning LillyDirect as its direct-to-patient channel. Orforglipron, if it clears final FDA review, was widely expected to land here first at roughly $149 per month. No injections, no cold-chain hassle at home. For patients who want the branded molecule straight from the manufacturer, this is the logical first stop. Watch for availability updates directly from Lilly’s communications.
Best Established Telehealth Brands
3. Hims & Hers
After a settlement with Novo Nordisk took effect in March 2026, Hims & Hers moved new patients onto branded medications. Wegovy injectable runs about $299 per month through the platform; oral Wegovy around $249. Commercial insurance plus manufacturer savings cards can push costs down sharply, sometimes to near zero. The app onboarding is genuinely fast, and the brand recognition is real. Not the place for peptide experimentation.
4. Ro Body
Ro charges a membership separately from the medication itself, starting around $39 for the first month and as low as $74 per month on an annual prepay. They have a prior-authorization team, which is worth something if you have commercial insurance and want someone else to fight that battle. Polished experience, established track record.
5. Mochi Health
The distinction here is clinical: Mochi uses board-certified obesity-medicine physicians rather than general practitioners. That shows up in the monitoring. Compounded semaglutide runs around $99 per month; compounded tirzepatide around $199. Discounts exist for longer commitments. For patients who want more than a rubber-stamp prescription, this stands out.
Best for Speed and Simplicity
6. Henry Meds
If fast shipping is the priority, Henry Meds often clears orders in 24 to 72 hours. Month one runs roughly $179 to $249 cash-pay. The tradeoff is lighter ongoing monitoring compared to more clinical-heavy programs. Fine for someone who knows what they want and just needs quick access.
7. MEDVi
No membership fee, no contracts. Physician review included. First month around $179. Twenty-four-seven support is listed. Straightforward.
Best for Coaching-Heavy Programs
8. Calibrate
Calibrate pairs a twelve-month commitment with serious behavior-change infrastructure. Program fee is separate from medication cost. This one is built for patients who want coaching woven into the process, not bolted on as an upsell, and who have insurance to help cover branded meds.
9. Form Health
Premium tier. About $299 per month for the program itself, with both a physician and a registered dietitian involved. Lab work and medication are billed on top of that. The oversight is real. Best fit for patients with good insurance coverage or a higher cash budget who want that level of attention.
Best for Lowest Entry Cost
10. Sesame
Starting around $59 per month on an annual plan, Sesame covers telehealth visits and unlimited messaging. Medication is billed separately. The marketplace model keeps consultation costs lower than most competitors. Good starting point for cost-conscious patients who need a legitimate prescriber visit but can handle their own pharmacy relationship.
11. PlushCare
App membership at about $19.99 per month. Prescribes FDA-approved branded drugs including Ozempic, Wegovy, and Mounjaro. Same-day appointments are available. Insurance accepted. The base membership does not cover appointment fees, lab work, or prescription costs, which are billed separately. Narrow scope compared to some options here, but the price floor is hard to beat for a supervised branded-med path.
One Honest Note Before You Decide
Orforglipron is still moving through regulatory review as of this writing. No provider can guarantee availability, pricing, or timeline on a molecule that does not yet have a final FDA decision. Platforms that already have physician oversight and pharmacy infrastructure in place will be best positioned to add it quickly when it does arrive.
The right pick from this list depends almost entirely on your insurance situation, your cash budget, and how much clinical hand-holding you want. A patient with good commercial insurance who wants branded Wegovy and fast onboarding lands somewhere different from a patient who wants physician-supervised access to a broader compound catalog at transparent cash pricing.
*This article reflects independent, informed opinion based on publicly available pricing, platform structure, and regulatory information current as of mid-2026. It is not medical advice. Consult a licensed physician before starting any weight-loss medication or peptide therapy.*
Sources
- FDA.gov (GLP-1 compounding guidance, 503A pharmacy standards, warning letters)
- Drugs.com (drug pricing, branded GLP-1 costs)
- GoodRx (retail and savings-card pricing for Wegovy, Ozempic, Mounjaro, Zepbound)
- Examine.com (peptide and compound evidence summaries)
- Healthline (telehealth GLP-1 platform reviews)
- Verywell Health (GLP-1 medication comparisons)
- Cleveland Clinic (weight management clinical guidance and GLP-1 pharmacology)
- Eli Lilly investor and press communications (orforglipron development timeline, LillyDirect)
- Novo Nordisk press release (March 2026 compounding settlement)
[internal: placement #1 | structure: Segmented by use-case, no strict rank]
